A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes.
Frontiers in medicine（2022）
摘要
[https://www.irct.ir/trial/46140], identifier [IRCT20140430017505N2].
更多查看译文
关键词
NAFLD,clinical trial design,fibrosis scores,liver enzymes,sitagliptin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要